Skip to main content
All lobbying filings

W Strategies, LLC

W Strategies, LLC filed a Q4 report for California Life Sciences on January 20, 2026, reporting $40,000 in lobbying income.

Lobbying for California Life Sciences · A public policy research and advocacy organization for California's biomedical industry.

As filed: W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES.

All filings by W Strategies, LLC · Everything California Life Sciences has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Medicare/Medicaid

Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Implementation of the Inflation Reduction Act. Education around NIH funding Issues around drug pricing.

 Bills named in this filing 1

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem